Symbol: |
SPRYD3
|
Description: |
SPRY domain containing 3 [Source:HGNC Symbol;Acc:25920]
|
Location: |
Chr12:53458388-53473204[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:83
Gene |
Compound |
Gen_sig |
Exp_pattern |
SPRYD3 |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.041 |
Up |
SPRYD3 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3-methoxy- phenyl)methylene]-, hydrochloride |
0.008 |
Up |
SPRYD3 |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.047 |
Down |
SPRYD3 |
NSC 652536 |
0.032 |
Up |
SPRYD3 |
NSC 655266 |
0.035 |
Up |
SPRYD3 |
NSC 655978 |
0.009 |
Up |
SPRYD3 |
NSC 65683 |
0.047 |
Down |
SPRYD3 |
2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. |
0.021 |
Up |
SPRYD3 |
NSC 667873 |
0.026 |
Up |
SPRYD3 |
Ethanamine, N,N-dimethyl-2-[4-(1,1-dimethylethyl)- 1-[(4-methylphenyl)methyl]cyclohexyloxy]-, (trans)-, (E)-2-butenedioate (fumaric acid) (1:1) |
0.043 |
Down |
SPRYD3 |
NSC 670299 |
0.047 |
Down |
SPRYD3 |
NSC 671134 |
0.03 |
Down |
SPRYD3 |
Benzoic acid, 2,4-dichloro-, 6-acetyl-1,2,3,4-tetrahydro- 4-oxo-1,3-diphenyl-2-thioxothieno[2,3-d]pyrimidin-5-yl ester |
0.005 |
Down |
SPRYD3 |
3-[2-pyrrolidino] ethoxy-17-butyl-17-aza-1,3,5(10)-estratriene-16,17.alpha.-dione |
0.004 |
Down |
SPRYD3 |
7-O-.beta.-D-Galactosyl-befeldin A |
0.013 |
Down |
Expression pattern: Sensitivity / Resistance
Total:6 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:26
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:17
Total:2 Current:1
[First] [Prev]  Next Last 
|